InvestorsHub Logo

WeeZuhl

02/20/18 11:24 AM

#284248 RE: Investintin #284247

Still, more than 10 years and nothing approved, no other companies approached Elite to use their technology, interest in the company is only strong in this forum






More than 10 years and nothing approved is a true statement, but it is not true that no other companies have approached Elite about the 2 bead tech. You can do your own DD on why your statement is false. Nor is it true that interest is only strong in this forum, as evidenced by the multiple collaborative agreements in place, such as SunGen. And besides that, none of those things is the bullshit that I was replying to. You said this:




if this technology works, the preliminary results would be out already, but it has been more than 10 years and nothing






And so I showed you the data you apparently didn't have, which proves that recreational abusers not only did not like snorting SequestOx, they actually *disliked* snorting it. There is no other snorting HAL study for any other drug which looks nearly so impressive as this. I certainly don't mind helping newbies understand the tech, but when misinformation is posted as fact, I'm more than happy to call it what it is-- BULLSHIT.




NASDAQ2020

02/20/18 11:37 AM

#284250 RE: Investintin #284247

LOL how many Immediate Release ADFs with ORAL AD Labeling have been approved to date, TIA

WeeZuhl

02/20/18 11:42 AM

#284252 RE: Investintin #284247

Still, more than 10 years and nothing approved







https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136598081


Elite started an ADF company multiple years before OxyContin came out. It would be nine more years until the movie OxyContin Express won the Peabody for documenting the craziness in Florida. By then, Elite had been less than a dime for nearly two years. ADF OxyContin didn't come out until 2010, and before that nobody ever heard of an ADF label. A lot has changed since then. We have a whole new language for describing ADF properties, testing for effectiveness, and certifying the label. My bet here is that it is worth something to have a unique ADF tech that can readily meet the requirements for chewing, snorting, and IV abuse deterrence labels for any opioid agonist and any time-release characteristic (even if it isn't first and isn't revolutionary). I own about one in 500 share of this very cool, very versatile ADF tech, and I'm very much looking forward to seeing how it turns out. Patience, my friend.







Chasing

02/20/18 12:14 PM

#284253 RE: Investintin #284247

Below the quote is all the proof that exists to support the claim

no other companies approached Elite to use their technology,

Jimmy Joe

02/20/18 12:52 PM

#284256 RE: Investintin #284247

10 years ago this ADF technology that Elite had was only a pipe dream.
NOW that they have several patents both US and international Elite's technology is NOT a pipedream.

By the way, just to make something clear, the FDA has no problems with Elite's technology. In fact the FDA likes it. The only matter in question for the FDA was for Elite's IR formulation of opioids, that being time to maximum concentration in the blood stream after a high fat meal.


Guess what? Seems like Elite may have solved that problem after disclosing results on the pilot testing.

NEXT!

Don'tDrinkTheKoolAid

02/20/18 5:32 PM

#284284 RE: Investintin #284247

It's not strong anymore I know several longs who stopped posting, sold and moved on. I can think of way better companies to own that are exploding to the upside.